Bio-Thera Solutions Ltd (688177) — Capital Reinvestment Ratio

Latest as of December 2021: 0.07x

Bio-Thera Solutions Ltd (688177) has a Capital Reinvestment Ratio of 0.07x as of December 2021, meaning it reinvests 0% of its operating cash flow (CN¥368.97 Million) in capital expenditures (CN¥26.25 Million). See Bio-Thera Solutions Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

CN¥368.97 Million

CNY

Capital Expenditures

CN¥26.25 Million

CNY

Data as of

Dec 2021

Most recent filing

Bio-Thera Solutions Ltd Capital Reinvestment Ratio (2021–2021)

This chart tracks Bio-Thera Solutions Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Bio-Thera Solutions Ltd (688177) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Bio-Thera Solutions Ltd (2021–2021)

Year-by-year Capital Reinvestment Ratio for Bio-Thera Solutions Ltd from 2021 to 2021. For live market cap and broader valuation context, see 688177 market cap.

Year	Reinvestment Ratio	Operating CF (CNY)	Capital Expenditures	YoY Change
2021	0.33x	CN¥236.27 Million	CN¥77.89 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow